Select Airway Specialized Proresolving Mediators Are Associated with Recovery from Nonviral Chronic Obstructive Pulmonary Disease Exacerbations
<b>Rationale:</b> Recovery from chronic obstructive pulmonary disease (COPD) exacerbations is heterogeneous and has a profound impact on disease trajectories. Resolution of airway inflammation is an active process that may be driven by specialized proresolving mediators (SPMs). <b>Objectives:</b> We sought to characterize the temporal change in SPMs in the sputum of patients with COPD during exacerbations, their association with exacerbation triggers, and exacerbation recovery. <b>Methods:</b> Participants were recruited from the London COPD Exacerbation Cohort between January 11, 2016, and April 30, 2018. Participants were reviewed at baseline, exacerbation onset, 1 week, 2 weeks, and 6 weeks during their exacerbation recovery. Sputum collection, nasopharyngeal swabs, phlebotomy, quality-of-life questionnaires, and spirometry were performed at each visit. SPMs were measured in sputum by liquid chromatography-tandem mass spectrometry. Respiratory viruses were measured by quantitative PCR and bacteria by microbiological culture. <b>Measurements and Main Results:</b> There were 68 exacerbations during the study period. Median time to symptomatic recovery was 21 days for viral exacerbations, compared with 13 days in nonviral exacerbations (<i>P</i> < 0.001). There was a significant increase in resolvin D1 (RvD1) at exacerbation onset in bacterial exacerbations but not in viral exacerbations. Lower levels of RvD1 were associated with prolonged respiratory symptoms during the 1-week and 2-week recovery time points. Exogenous RvD1 significantly reduced IL-6 and CXCL8 response to rhinovirus infection in COPD bronchial epithelial cells. <b>Conclusions:</b> There is a dynamic temporal change in airway SPMs during COPD exacerbations. Reduced levels of RvD1 were associated with prolonged respiratory symptoms. SPMs may be a potential therapeutic approach to promote exacerbation recovery.
Authors
- Jadwiga A. Wedzicha (ORCID: https://orcid.org/0000-0001-9642-1261)
- Christopher Michael Orton (ORCID: https://orcid.org/0000-0002-9167-5462)
- Dexter Wiseman (ORCID: https://orcid.org/0000-0002-6398-7450)
- Alexander Mackay (ORCID: https://orcid.org/0000-0002-6801-800X)
- Tata Kebadze
- Faisal Kamal (ORCID: https://orcid.org/0000-0002-6842-506X)
- Pankaj Kumar Bhavsar (ORCID: https://orcid.org/0000-0003-3511-756X)
- Andrew I. Ritchie
- Bruce David Levy (ORCID: https://orcid.org/0000-0001-9515-5731)
- Sebastian Lennox Johnston (ORCID: https://orcid.org/0000-0003-3009-9200)
- Aran Singanayagam (ORCID: https://orcid.org/0000-0001-9849-0033)
- James P. Allinson (ORCID: https://orcid.org/0000-0002-3117-7533)
- Adam J. Byrne (ORCID: https://orcid.org/0000-0003-2736-8174)
- Lydia Finney (ORCID: https://orcid.org/0000-0003-2226-9513)
- Federico Baraldi (ORCID: https://orcid.org/0009-0007-5649-8409)
- Samuel V. Kemp (ORCID: https://orcid.org/0000-0002-6639-0166)
- Melody G. Duvall (ORCID: https://orcid.org/0000-0002-4173-3628)
- Mairi Macleod (ORCID: https://orcid.org/0000-0002-0910-4485)
- Peter Fenwick
- Jordina Mah
Institutions
- University College Dublin (IE)
- Brigham and Women's Hospital (US)
- Boston Children's Hospital (US)
- British Airways (United Kingdom) (GB)
- Nottingham University Hospitals NHS Trust (GB)
- University of Ferrara (IT)
- Royal Brompton Hospital (GB)
- Center for Pain and the Brain (US)
- Imperial College London (GB)
Publication Details
- Journal
- American Journal of Respiratory and Critical Care Medicine
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1164/rccm.202407-1325oc
- Citations
- 6
- Primary Topic
- Neonatal Respiratory Health Research
- Type
- article
- Field-Weighted Citation Impact
- 9.11